Vor BiopharmaVOR
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 80 institutions reported holding Vor Biopharma Inc. (VOR) in their 13F filings, up 25 from Q4 2025. 32 opened new positions and 9 sold out. The largest holders were TCG Crossover Management, LLC ($96.5M), Ra Capital Management, L.P. ($96.4M) and FCPM III Services B.V. ($73.5M). 4 famous investors held it, including Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Vor Biopharma Inc.
- CUSIP
- 929033207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 32 | $172.1M |
| Exits | 9 | $6.2M |
All 13F filers, Q4 2025 → Q1 2026: 15,915,350 shares bought and 1,875,190 shares sold, net +14,040,160 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 80 holders
| TCG Crossover Management, LLC | 2.76% | New | 5,673,078 | $96.5M |
| Ra Capital Management, L.P. | 1.02% | No change | 5,404,998 | $96.4M |
| FCPM III Services B.V. | 10.17% | Add +13.8% | 4,117,354 | $73.5M |
| Venrock Adviser, LLC | 2.03% | Add +56.5% | 3,041,719 | $54.3M |
| Frazier Life Sciences Management, L.P. | 1.17% | No change | 2,543,939 | $45.4M |
| Caligan Partners LP | 2.43% | Add +108.1% | 1,925,066 | $34.3M |
| Great Point Partners LLC | 7.65% | Add +27.7% | 1,750,000 | $31.2M |
| Paradigm Biocapital Advisors LP | 0.64% | No change | 1,750,000 | $31.2M |
| FMR LLC | 0.00% | Reduce -39.0% | 1,539,670 | $27.5M |
| Vanguard Capital Management LLC | 0.00% | — | 1,433,280 | $25.6M |
| Marshall Wace, LLP | 0.02% | New | 1,153,276 | $20.6M |
| State Street Corp. | 0.00% | Add +1128.4% | 1,118,458 | $20.0M |
| NEXTBio Capital Management LP | 8.28% | No change | 999,967 | $17.8M |
| BlackRock, Inc. | 0.00% | Add +70.7% | 794,759 | $14.2M |
| Logos Global Management LP | 0.69% | Add +650.0% | 750,000 | $13.4M |
| Rosalind Advisors, Inc. | 5.12% | New | 700,000 | $12.5M |
| Boothbay Fund Management, LLC | 0.24% | New | 555,702 | $9.9M |
| UBS Group AG | 0.00% | Add +67.2% | 488,368 | $8.7M |
| Braidwell LP | 0.32% | New | 466,774 | $8.3M |
| Geode Capital Management, LLC | 0.00% | Add +84.4% | 342,573 | $6.1M |
| Clearline Capital LP | 0.45% | New | 326,168 | $5.8M |
| Sphera Funds Management LTD. | 0.99% | Reduce -21.6% | 321,917 | $5.7M |
| Laurion Capital Management LP | 0.56% | Add +0.5% | 318,670 | $5.7M |
| Propel Bio Management, LLC | 3.52% | New | 314,543 | $5.6M |
| Goldman Sachs Group Inc. | 0.00% | Add +79.8% | 261,891 | $4.7M |
| Millennium Management | 0.00% | Add +15.2% | 258,587 | $4.6M |
| Susquehanna International Group, LLP | 0.01% | Add +1469.7% | 232,608 | $4.1M |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 185,511 | $3.3M |
| Jump Financial, LLC | 0.05% | New | 173,028 | $3.1M |
| Tudor Investment Corporation | 0.01% | Reduce -9.0% | 152,571 | $2.7M |
| Citadel Advisors | 0.00% | Reduce -65.7% | 148,768 | $2.7M |
| Renaissance Technologies | 0.00% | New | 128,839 | $2.3M |
| Morgan Stanley | 0.00% | Add +310.1% | 116,721 | $2.1M |
| Bank of America Corp. | 0.00% | Add +28408.1% | 112,892 | $2.0M |
| Axiom Investors LLC | 0.02% | New | 95,745 | $1.7M |
| Quadrature Capital Ltd | 0.02% | Add +186.0% | 76,630 | $1.4M |
| Jane Street Group, LLC | 0.00% | Reduce -17.3% | 75,890 | $1.4M |
| Northern Trust Corp. | 0.00% | Add +65.7% | 64,549 | $1.2M |
| Johnson & Johnson | 0.15% | No change | 53,732 | $959K |
| Simplify Asset Management Inc. | 0.01% | New | 53,510 | $955K |
| Rafferty Asset Management, LLC | 0.00% | New | 50,505 | $901K |
| Brevan Howard Capital Management LP | 0.01% | New | 42,217 | $753K |
| Irenic Capital Management LP | 0.05% | New | 32,663 | $583K |
| Engineers Gate Manager LP | 0.01% | Reduce -4.7% | 26,880 | $480K |
| Squarepoint Ops LLC | 0.00% | Add +38.0% | 25,482 | $455K |
| Sarissa Capital Management LP | 0.29% | No change | 25,399 | $453K |
| Bollard Group LLC | 0.01% | No change | 23,987 | $428K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 22,216 | $396K |
| Profund Advisors LLC | 0.01% | New | 22,015 | $393K |
| Scientech Research LLC | 0.22% | New | 15,047 | $268K |
| Axq Capital, LP | 0.03% | New | 15,019 | $268K |
| Independent Financial Group, LLC | 0.01% | Reduce -17.8% | 13,975 | $249K |
| Sei Investments Co. | 0.00% | New | 13,716 | $245K |
| Vanguard Global Advisers, LLC | 0.00% | — | 12,875 | $230K |
| WINTON GROUP Ltd | 0.01% | New | 11,870 | $212K |
| Cannon Global Investment Management, LLC | 0.51% | New | 11,700 | $209K |
| Invesco Ltd. | 0.00% | New | 11,600 | $207K |
| Diametric Capital, LP | 0.05% | New | 10,070 | $180K |
| Group One Trading LLC | 0.01% | New | 9,065 | $162K |
| China Universal Asset Management Co., Ltd. | 0.01% | Add +168.3% | 7,368 | $131K |
| Citigroup Inc. | 0.00% | Reduce -15.3% | 5,373 | $96K |
| JPMorgan Chase & Co. | 0.00% | Add +88.8% | 4,364 | $64K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +100.5% | 3,466 | $62K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | New | 3,513 | $52K |
| BNP Paribas Financial Markets | 0.00% | Add +877.3% | 2,844 | $51K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +164.5% | 2,166 | $39K |
| GF Fund Management Co. LTD. | 0.00% | Add +12.7% | 372 | $7K |
| Quantbot Technologies LP | 0.00% | New | 307 | $5K |
| PNC Financial Services Group, Inc. | 0.00% | New | 246 | $4K |
| Royal Bank of Canada | 0.00% | Add +2742.9% | 199 | $4K |
| Barclays PLC | 0.00% | Reduce -90.3% | 136 | $2K |
| Allworth Financial LP | 0.00% | Add +2333.3% | 73 | $1K |
| Parallel Advisors, LLC | 0.00% | New | 48 | $856 |
| MAI Capital Management | 0.00% | No change | 40 | $714 |
| Signaturefd, LLC | 0.00% | New | 39 | $696 |
| Ameritas Advisory Services, LLC | 0.00% | New | 37 | $660 |
| Fortitude Family Office, LLC | 0.00% | New | 31 | $553 |
| WPG Advisers, LLC | 0.00% | New | 21 | $375 |
| SBI Securities Co., Ltd. | 0.00% | No change | 3 | $54 |
| Wells Fargo & Company | 0.00% | No change | 1 | $18 |
"% of holder's portfolio" is VOR's weight in each manager's 13F, not the share of Vor Biopharma Inc. the manager owns.